GLP1R and type 2 diabetes mellitus: In any case, the glucagonostatic effect at low glucose remains controversial, as the glucagonostatic effects of GLP-1 receptor agonists have mainly been described during fasting hyperglycaemia or postprandial hyperglycaemia as in type 2 diabetes [50, 51].